Skip to main content

Phibro Animal Health Corp

PAHC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001069899

No open-market purchases or sales by Phibro Animal Health Corp insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $660.4M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Phibro Animal Health Corp changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of PAHC: Q2 2021 compared with Q3 2021
MeasureQ2 2021Of which not filed for Q3 2021Q3 2021Change
Holders1461143−2
Shares21.3M2220.4M−884.5K (−4.2%)
Value$615.1M$1.00K$439.8M−$175.4M (−28.5%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (13)

Institutions that held Phibro Animal Health Corp at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to PAHC in Q3 2021
InstitutionSharesValue% of portfolio
Tudor Investment Corp Et Al33,665$725.0K0.01%
SG Americas Securities, LLC20,998$452.0K0.00%
PDT Partners, LLC18,479$398.0K0.03%
Lazard Asset Management LLC2,261$48.0K0.00%
Harbour Investments, Inc.435$9.00K0.00%
Signaturefd, LLC222$5.00K0.00%
Performa Ltd (US), LLC100$2.00K0.00%
Quadrant Capital Group LLC62$1.00K0.00%
Bartlett & Co. Wealth Management LLC21$4520.00%
Bartlett & Co. LLC21$00.00%
Rockefeller Capital Management L.P.16$00.00%
Meridian Wealth Partners, LLC9$00.00%
Kowal Investment Group, LLC1$00.00%

Sold out (15)

Institutions that held Phibro Animal Health Corp at the end of Q2 2021 and filed for Q3 2021 without it.

Not filed for Q3 2021 yet (1)

Institutions that held Phibro Animal Health Corp at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PAHC in Q2 2021 that haven't filed for Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
CWM, LLC22$1.00K